Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Summary 
Charles Reed Cherington is an entrepreneur who founded Paratus Capital Management, Amberjack Capital Partners LP, Cherington Capital LLC and Ara Advisers LLC. Currently, he is Chairman for Brooklyn ImmunoTherapeutics, Inc., Manager of Brooklyn ImmunoTherapeutics LLC (a subsidiary of Brooklyn ImmunoTherapeutics, Inc.), Partner at Amberjack Capital Partners LP and Managing Partner at Ara Advisers LLC. Charles Reed Cherington is also Manager for Brooklyn ImmunoTherapeutics LLC and on the board of 8 other companies.

In the past Mr. Cherington occupied the position of President & Director at FCG Chemical, Inc., Vice President for Vietnam Fund Ltd., Partner at Paratus Capital Management, Principal at CS First Boston Pacific, Inc. and Partner at Cherington Capital LLC.

Charles Reed Cherington received an MBA from The University of Chicago and an undergraduate degree from Wesleyan University.


Current positions of Charles Reed Cherington 
NameTitle Since
Beard Energy Transition Acquisition Corp.
(Investment Holding Companies)
Independent Director 2021
Brooklyn ImmunoTherapeutics, Inc.
(Biotechnology & Medical Research)
Director 2021
Amberjack Capital Partners LP Partner & Founder 2011
The Conservation Fund Director -
Soane Energy LLC Director -
Aegis Chemical Solutions LLC Director -
Benchmark Completions LLC Director -
Brooklyn Immunotherapeutics Investors LP Director -
Utility Global, Inc. Director -
Px Holdco3 Ltd. Director 2021
Brooklyn ImmunoTherapeutics LLC Manager 2018
Ara Advisers LLC Managing Partner 2016


Holdings of Charles Reed Cherington 
NameEquities%Valuation
Brooklyn ImmunoTherapeutics, Inc. (BTX)
(Biotechnology & Medical Research)
5,894,10110.3%6,188,806 USD
BROOKLYN IMMUNOTHERAPEUTICS PFCV A19,26412.3%20,227 USD


Charles Reed Cherington: Personal Network 
Most Read News 
05/11CATHIE WOOD : Tumble in Coinbase pushes Wood's ARK fund closer to pandemic low
RE
05/12MASAYOSHI SON : SoftBank Vision Fund posts $26 billion loss; Son pledges defence
RE
05/14ELON MUSK : Elon Musk says Twitter legal team told him he violated an NDA
RE
05/11ELON MUSK : Musk's delay in disclosing Twitter stake triggers SEC probe - WSJ
RE
05/05LARRY ELLISON : Musk to lead Twitter temporarily after $44 billion takeover - source
RE
05/10ELON MUSK : Elon Musk says Tesla open to buying a mining company
RE
05/04WARREN BUFFETT : Berkshire shareholders overwhelmingly vote to keep Buffett chairman
RE
05/05JACK DORSEY : Dorsey-led Block beats operating profit estimates, shares surge 10%
RE
05/17JPMorgan shareholders vote disapproval of CEO Dimon's special payout
RE
05/06MARTIN SORRELL : Sorrell's S4 sees good 2022 after publishing delayed results
RE
More news


© 2022 People and Ownership :   
Charles Reed Cherington : Connections